The global automated cannabis testing market is poised for substantial expansion over the next decade, with projections indicating a Compound Annual Growth Rate (CAGR) of approximately 11% to 13% from 2022 to 2032. This surge is attributed to the increasing adoption of automation in cannabis testing labs worldwide, coupled with rising demand for high-quality cannabis-based medical products.
As the cannabis industry undergoes rapid growth and evolution, the need for robust testing methodologies becomes paramount. Both medical and recreational cannabis sectors are witnessing widespread acceptance and legalization across numerous regions. Consequently, ensuring product safety and quality has become a top priority, driving the demand for rigorous testing procedures.
Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-9066
The advent of automated testing solutions has revolutionized the cannabis testing landscape, offering streamlined processes and enhanced efficiency. Key drivers behind this market growth include stringent regulatory requirements mandated by governments and health agencies. Automated systems enable cannabis testing facilities to meet these regulations with precision and accuracy, conducting a diverse array of tests such as cannabinoid profiling, pesticide screening, microbial analysis, and heavy metal detection.
Automation presents numerous advantages for cannabis testing facilities, notably in reducing the risk of human error and increasing sample throughput. By processing large volumes of samples in shorter time frames, automated systems not only improve operational efficiency but also lower overall costs. Moreover, these systems ensure data accuracy and reproducibility, crucial factors for maintaining product quality and consumer trust.
“Automation is revolutionizing the cannabis testing industry, enabling laboratories to meet regulatory requirements efficiently while ensuring product consistency and safety,” remarked FMI. “Our automated solutions empower testing facilities to achieve higher throughput, lower operational costs, and deliver reliable results, ultimately driving confidence in the quality of cannabis products.”
With automation poised to play an increasingly pivotal role in cannabis testing, stakeholders across the industry are primed to capitalize on the market’s growth trajectory. As consumer demand for safe and high-quality cannabis products continues to escalate, automated testing solutions stand as indispensable tools for ensuring compliance and fostering trust in this burgeoning market.
Key takeaways from the automated cannabis testing market report:
- The automated cannabis testing market is expected to grow at a significant CAGR of 11-13% from 2023 to 2033.
- The growth of the market is attributed to the rising adoption of automation in cannabis testing laboratories and increasing demand for high-quality cannabis-based medical products across the world.
- North America is expected to remain the dominant market for automated cannabis testing throughout the forecast period.
- The European market is also expected to witness significant growth during the forecast period.
The automated cannabis testing market is poised for significant growth in the coming years, driven by the increasing demand for high-quality cannabis-based medical products and the growing adoption of automation in cannabis testing laboratories.
Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9066
Key Companies Profiled:
- Medicinal Genomics Corp.
- PerkinElmer Inc.
- Agilent Technologies, Inc.
- Todaro robotics
- Hamilton Company
- Quantum Analytics
- Shimadzu Scientific Instruments
Key Segments Profiled in the Automated Cannabis Testing Industry Survey:
By Product Type:
- Chromatography Based Analyzer
- Spectroscopy Based Analyzer
By Application:
- Pain Management
- Seizures
- Sclerosis
- Others
By End User:
- Consumers
- Regulators
- Laboratories
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APEJ
- Japan
- Middle East & Africa
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/9066
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
